Publications:42
- Home
- Profiles
Mount Sinai DoctorsPaul Latkany, MD
Ophthalmology (Eye)
No Patient Experience Ratings
- About Me
- Education & Certifications
- Insurance
- Publications
- Industry Relationships
About Me
Language
Position
Hospital Affiliations
- Mount Sinai Morningside
- New York Eye and Ear Infirmary of Mount Sinai
- Mount Sinai West
About Me
Language
Position
Hospital Affiliations
- Mount Sinai Morningside
- New York Eye and Ear Infirmary of Mount Sinai
- Mount Sinai West
Education
MD, Pace University
Residency, Internal Medicine
Bellevue Hospital Center
Residency, Ophthalmology
St. Luke's-Roosevelt Hospital Center-Roosevelt Division
Fellowship, Retina and Vitreous Surgery
Indiana University Hospitals School of Medicine
Fellowship, Ophthalmology
Wilmer Eye Institute at Green Spring Station
Certifications
American Board of Ophthalmology
Insurance Information
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Effectiveness of Frequently Used TNF Inhibitors vs. Conventional Immunosuppressive Therapies for Noninfectious Uveitis. Sapna S. Gangaputra, Craig W. Newcomb, Gui Shuang Ying, Kurt A. Dreger, Tonetta Fitzgerald, Pichaporn Artornsombudh, Srishti Kothari, Teresa L. Liesegang, James T. Rosenbaum, H. Nida Sen, Eric B. Suhler, Jennifer E. Thorne, Nirali P. Bhatt, C. Stephen Foster, Douglas A. Jabs, Grace A. Levy-Clarke, Careen Y. Lowder, Debra A. Goldstein, Gary N. Holland, Glenn J. Jaffe, Janet L. Davis, Nisha R. Acharya, Paul A. Latkany, Russell W. Read, Sunir J. Garg, Yannek I. Liederman, Jeanine M. Buchanich, John H. Kempen. Ocular Immunology and Inflammation
- Port Delivery System with Ranibizumab vs Monitoring in Nonproliferative Diabetic Retinopathy Without Macular Edema: The Pavilion Randomized Clinical Trial. Dante J. Pieramici, Carl C. Awh, Margaret Chang, Andres Emanuelli, Nancy M. Holekamp, Allen Y. Hu, Ivan J. Suñer, Charles C. Wykoff, Christopher Brittain, Dena Howard, Carlos Quezada-Ruiz, Anjana Santhanakrishnan, Paul Latkany. JAMA Ophthalmology
- Use of immunosuppression and subsequent cancer incidence: cohort study. Jeanine M. Buchanich, Craig W. Newcomb, Terri L. Washington, Charles Stephen Foster, Lucia Sobrin, Jennifer E. Thorne, Douglas Alan Jabs, Eric B. Suhler, James T. Rosenbaum, Hatice Nida Sen, Grace A. Levy-Clarke, Robert B. Nussenblatt, Nirali P. Bhatt, Careen Y. Lowder, Debra A. Goldstein, Yannek I. Leiderman, Nisha R. Acharya, Gary N. Holland, Russell W. Read, James P. Dunn, Kurt A. Dreger, Pichaporn Artornsombudh, Hosne A. Begum, Tonetta D. Fitzgerald, Srishti Kothari, Abhishek R. Payal, Ebenezer Daniel, Sapna S. Gangaputra, Roje Oktay Kaçmaz, Teresa L. Liesegang, Siddharth S. Pujari, Naira Khachatryan, Armin Maghsoudlou, Hilkiah K. Suga, Clara M. Pak, Kathy J. Helzlsouer, John H. Kempen, Hilkiah K. Suga, Clara Pak, Lucia Sobrin, John Caccaviello, C. Stephen Foster, R. Oktay Kacmaz, Siddharth S. Pujari, Pichaporn Artornsombudh, Srishti Kothari, Naira Khachatryan, Armin Maghsoudlou, Douglas A. Jabs, Paul A. Latkany. BMJ Oncology
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Latkany has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. Latkany has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.